Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
Cas No. | 1096708-71-2 |
---|---|
Purity | ≥98% |
Formula | C17H12Cl2F3N7O2S |
Formula Wt. | 506.30 |
IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
http://clinicaltrials.gov/show/NCT01425008
σ1 antagonist.
Toxin produced by Aspergillus.
A bacteriocin
GHB agonist, D2/3 antagonist.
Flavonol glycoside originally found in Epimediu...
Polyvinyl pyrrolidone polymer, disinfectant.
Statin; HMG-CoA reductase inhibitor.
Diterpene found in tobacco plants and cigarette...
Mycotoxin produced by Aspergillus; actin polyme...
Docetaxel impurity
Mycotoxin contaminant found in cereal grains.
Glucocorticoid
Lignan found in Magnolia; GABA-A potentiator.
BRD binding agent, CDK1/2/5/9 inhibitor.
Steroid hormone, contraceptive; PR agonist.
FAK inhibitor.
ALK, ROS1, c-MET inhibitor.
Potential PKD binding agent.
β1/2-adrenergic agonist.
Recombinant chimeric protein containing Trepone...